{{Rsnum
|rsid=11941399
|Chromosome=4
|position=166534341
|Orientation=plus
|GMAF=0.3306
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 7.8 | 92.2
| HCB | 28.7 | 51.5 | 19.9
| JPT | 15.9 | 47.7 | 36.4
| YRI | 46.9 | 45.6 | 7.5
| ASW | 33.3 | 47.4 | 19.3
| CHB | 28.7 | 51.5 | 19.9
| CHD | 28.7 | 54.6 | 16.7
| GIH | 5.1 | 28.6 | 66.3
| LWK | 54.5 | 35.5 | 10.0
| MEX | 7.1 | 35.7 | 57.1
| MKK | 29.1 | 53.0 | 17.9
| TSI | 0.0 | 20.4 | 79.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=1E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}